2023 Annual Meeting | S21 - Acute and Post-Acute Sequelae of COVID-19

Date Monday 04/24/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Ayush Batra, MD, Monica M. Diaz, MD

Topic(s) Infectious Disease

Learning Objectives A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes for question and answer with the author.

CME Available 2.00 CME credits

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
03:30 PM - 03:42 PM EST	Abstract	001 - Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy Roberto Alfonso, PhD
03:42 PM - 03:54 PM EST	Abstract	002 - Machine Learning Models to Predict Severity and Mortality of COVID-19 Using Neurological Symptoms Manouchehr Amanat
03:54 PM - 04:06 PM EST	Abstract	003 - Cognitive Concerns are a Risk Factor for Mortality in People with Human Immunodeficiency Virus and COVID-19 Emily A. Rudmann
04:06 PM - 04:18 PM EST	Abstract	004 - The MRI Analysis of 300 Subjects Revealed Grey Matter Atrophy of the Frontal Lobe and Limbic System in Four SARS-CoV-2 Strains Lucas S. Silva, MD
04:18 PM - 04:30 PM EST	Abstract	005 - Coronavirus 2019: Clinicopathological Update David S. Younger, MD, DrPH, MPH, MS
04:30 PM - 04:42 PM EST	Abstract	006 - Serum And Cerebrospinal Fluid Antibody Signatures Track With Outcome Of Neurologic Post-Acute Sequelae Of SARS-Cov-2 Infection (NeuroPASC) Marianna Spatola, MD, PhD
04:42 PM - 04:54 PM EST	Abstract	007 - Anxiety And Depression Are Associated With Limbic Atrophy And Severe Disruption Of Brain Functional Connectivity After Mild COVID-19 Infection Lucas S. Silva, MD
04:54 PM - 05:06 PM EST	Abstract	008 - Changes In Cognitive Functioning In Patients Seeking Treatment For “Brain Fog” Through A Post-Covid Treatment Clinic Shruti P. Agnihotri, MD
05:06 PM - 05:18 PM EST	Abstract	009 - Effect of Human Immunodeficiency Virus Infection on the Incidence and Severity of Neurological Post-Acute Sequelae of COVID-19 Mustafa Jaffry
05:18 PM - 05:30 PM EST	Abstract	010 - Long-COVID-19 cognitive disfunction: strain-specific effects on 452 subjects Italo Karmann Aventurato, MD

Faculty Disclosures
Saud Sadiq, BS, FAAN	Ms. Brewi has nothing to disclose.
David S. Younger, MD, DrPH, MPH, MS	Dr. Younger has nothing to disclose.
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Jerry Lin, BS	Mr. Lin has nothing to disclose.
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
M. B. Westover, MD, PhD	Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Shruti P. Agnihotri, MD	The institution of Dr. Agnihotri has received research support from Roche/ Genentech.
Ayush Batra, MD	The institution of Dr. Batra has received research support from GeNeuro SA. Dr. Batra has received publishing royalties from a publication relating to health care.
	No disclosure on file
Haitham Alabsi, DO	Dr. Alabsi has received personal compensation for serving as an employee of Biogen.
Shibani S. Mukerji, MD, PhD	Dr. Mukerji has stock in Gilead Science. Dr. Mukerji has stock in Ranpack. Dr. Mukerji has stock in Snowflake. An immediate family member of Dr. Mukerji has stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.
Richard Kennedy	Richard Kennedy has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institutes of Health. The institution of Richard Kennedy has received research support from National Institutes of Health.
Monica M. Diaz, MD	The institution of Dr. Diaz has received research support from Alzheimer's Association. The institution of Dr. Diaz has received research support from ��ɫ��. The institution of Dr. Diaz has received research support from Merck. The institution of Dr. Diaz has received research support from CorEvitas. The institution of Dr. Diaz has received research support from Celgene Corporation/Bristol-Myers Squibb. The institution of Dr. Diaz has received research support from Novartis. The institution of Dr. Diaz has received research support from Bodford Family Transverse Myelitis Center Fund.
Marina K. Alvim	Dr. Alvim has nothing to disclose.
Marianna Spatola, MD, PhD	The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation.
Douglas R. Wilcox, MD, PhD	Dr. Wilcox has nothing to disclose.
Beatriz Costa	Miss Costa has nothing to disclose.
Sara Mariotto, MD, PhD	Dr. Mariotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen, Sanofi, Alexion, Roche, TSF, Dynamics, UCB, Novartis, Amgen, AAN. The institution of Dr. Mariotto has received research support from Ministero della Salute Italiano. The institution of Dr. Mariotto has received research support from TSF. The institution of Dr. Mariotto has received research support from GJF. The institution of Dr. Mariotto has received research support from Lundbeck.
Italo Karmann Aventurato, MD	Dr. Karmann Aventurato has received research support from Coordenadoria de Aperfeiçoamento de Pessoal de Ensino Superior (CAPES). Dr. Karmann Aventurato has received research support from Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP).
Mariana R. Brito, MD	No disclosure on file
Lucas S. Silva, MD	Dr. Silva has nothing to disclose.
Mustafa Jaffry	Mr. Jaffry has nothing to disclose.
Kazim Jaffry	Mr. Jaffry has nothing to disclose.
Kranthi K. Mandava	Mr. Mandava has nothing to disclose.
Morgan C. Roche	Ms. Roche has nothing to disclose.
Joyce Lei	Miss Lei has nothing to disclose.
Roberto Alfonso, PhD	Mr. Alfonso has nothing to disclose.
Jiayuan Liu	Ms. Liu has nothing to disclose.
Manouchehr Amanat	Mr. Amanat has nothing to disclose.
Muhammed Ors	Mr. Ors has nothing to disclose.
Ronak U. Trivedi	Mr. Trivedi has nothing to disclose.
Emily A. Rudmann	Ms. Rudmann has nothing to disclose.
Anam K. Shaikh	Miss Shaikh has nothing to disclose.
Mona Salehi	Dr. Salehi has nothing to disclose.
Antonia De Oliveira	No disclosure on file
Rafael Joao	Mr. Joao has nothing to disclose.
Galit Alter	No disclosure on file
Sudeshna Das	No disclosure on file
Alessandro Dinoto, MD	The institution of Dr. Dinoto has received research support from Encephalitis International . The institution of Dr. Dinoto has received research support from Autoimmune Encephalitis Alliance.

��ɫ����

��ɫ����

��ɫ��

��ɫ��